Cite
HARVARD Citation
Coleman, R. et al. (2017). Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 390 (10106), pp. 1949-1961. [Online].